It is unknown if the increased incidence of GA found in certain trials after the use of anti-VEGF therapies for nAMD is due to the therapy or is part of…
AI in Diabetic Retinopathy The primary goal of using AI for diabetic retinopathy (DR) is to screen for proliferative diabetic retinopathy (PDR) and diabetic macular edoema (DME), the two leading…